Target
Bromodomain-containing protein 9 [133-239]
Ligand
BDBM50183449
Substrate
n/a
Meas. Tech.
BRD9 Bromodomain TR-FRET Competition Binding Assay
IC50
55±n/a nM
Citation
 Zhou, QBocker, MMillan, DSChan, HMSoares, LNetherton, MRRuppel, SKYang, ZLowe, JTBrucelle, F Methods and compounds for treating disorders US Patent  US11773085 Publication Date 10/3/2023 
Target
Name:
Bromodomain-containing protein 9 [133-239]
Synonyms:
BRD9 | BRD9_HUMAN | Bromodomain-containing protein 9 (BRD9)(133-239)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
12383.34
Organism:
Homo sapiens (Human)
Description:
aa 133-239
Residue:
107
Sequence:
PAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSK
  
Inhibitor
Name:
BDBM50183449
Synonyms:
CHEMBL3823101 | US11773085, Compound B23
Type:
Small organic molecule
Emp. Form.:
C20H23N3O3
Mol. Mass.:
353.4149
SMILES:
COc1cc(c(OC)cc1CN(C)C)-c1cn(C)c(=O)c2cnccc12
Structure:
Search PDB for entries with ligand similarity: